“Live” sperm quality IIn 2024, Beikang Mical’s independently develop ultra-low temperature liquid nitrogen storage
system BSG800 was approv for the national mical device registration certificate and was select into
the list of Jiangsu Province’s first major equipment, reaching the international leading technology level.
It is worth noting that this is the first intelligent ultra-low temperature storage system in China design for the “safe” and “long-term” preservation of embryo fertility.
In 2024, Beikang Mical’s independently develop intelligent mauritius email list 150000 contact leads sperm quality analyzer BKA210 obtain a
registration certificate, becoming the world’s first device to achieve accurate morphological detection of
“live” sperm. The company has launch AI sperm clinical research in collaboration with 18 leading
centers in China, and complet clinical verification of 500,000 sperm morphologies
Which was highly
prais by clinical experts and embryologists at the 2024 Annual Meeting of the Chinese Mical
Association. The market prospects of this device are html5 foundation and architecture construction broad, not only limit to assist reproductive
centers, but also covering the global andrology market. As people pay more and more attention to
reproductive health and sperm quality, the BKA210 intelligent sperm quality analyzer is expect to
play an important role in these areas and provide strong support for mical diagnosis and treatment.
Macros Meseguer, a European full-time culture expert, has shown that using the GERI full-time culture incubator,
Clinical pregnancy rate increas by at least 15%, and live birth rate increas by at least 5.8%
15 years of experience in assist reproductive technology, focusing on product development and registration
Beikang Mical, after fifteen years of intensive cultivation, has been committ to focusing on product
research and development and registration, especially in the field of assist reproduction.
The company has invest in R&D innovation and team building. With profound accumulation and
unremitting efforts, it finally usher in the glorious trust review moment of registration and certification of its
product pipeline in 2024. This series of innovative technologies and products not only injects fresh vitality into the clinical practice of assist reproduction, but also fills the gap in domestic reliance on imports and lack of register products in many key areas, demonstrating Beikang Mical’s outstanding contribution to promoting the advancement of domestic reproductive health technology “Live” sperm quality.